318 related articles for article (PubMed ID: 37071420)
1. Association of COVID-19 Infection With Incident Diabetes.
Naveed Z; Velásquez García HA; Wong S; Wilton J; McKee G; Mahmood B; Binka M; Rasali D; Janjua NZ
JAMA Netw Open; 2023 Apr; 6(4):e238866. PubMed ID: 37071420
[TBL] [Abstract][Full Text] [Related]
2. Risk of major adverse cardiovascular events after SARS-CoV-2 infection in British Columbia: a population-based study.
Velásquez García HA; Wong S; Jeong D; Binka M; Naveed Z; Wilton J; Hawkins NM; Janjua NZ
Am J Med; 2024 Apr; ():. PubMed ID: 38670520
[TBL] [Abstract][Full Text] [Related]
3. Risks and burdens of incident diabetes in long COVID: a cohort study.
Xie Y; Al-Aly Z
Lancet Diabetes Endocrinol; 2022 May; 10(5):311-321. PubMed ID: 35325624
[TBL] [Abstract][Full Text] [Related]
4. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients.
Abel KM; Carr MJ; Ashcroft DM; Chalder T; Chew-Graham CA; Hope H; Kapur N; McManus S; Steeg S; Webb RT; Pierce M
JAMA Netw Open; 2021 Nov; 4(11):e2134803. PubMed ID: 34783824
[TBL] [Abstract][Full Text] [Related]
5. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
6. Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.
Xu E; Xie Y; Al-Aly Z
Lancet Diabetes Endocrinol; 2023 Feb; 11(2):120-128. PubMed ID: 36623520
[TBL] [Abstract][Full Text] [Related]
7. Risk of Severe COVID-19-Related Outcomes among Patients with Cirrhosis: A Population-Based Cohort Study in Canada.
Velásquez García HA; Adu PA; Okonkwo-Dappa A; Makuza JD; Cua G; Binka M; Wilton J; Sbihi H; Janjua NZ
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543717
[TBL] [Abstract][Full Text] [Related]
8. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
Xie Y; Choi T; Al-Aly Z
JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
[TBL] [Abstract][Full Text] [Related]
9. Perinatal Complications in Individuals in California With or Without SARS-CoV-2 Infection During Pregnancy.
Ferrara A; Hedderson MM; Zhu Y; Avalos LA; Kuzniewicz MW; Myers LC; Ngo AL; Gunderson EP; Ritchie JL; Quesenberry CP; Greenberg M
JAMA Intern Med; 2022 May; 182(5):503-512. PubMed ID: 35311909
[TBL] [Abstract][Full Text] [Related]
10. Association of Influenza Vaccination With SARS-CoV-2 Infection and Associated Hospitalization and Mortality Among Patients Aged 66 Years or Older.
Hosseini-Moghaddam SM; He S; Calzavara A; Campitelli MA; Kwong JC
JAMA Netw Open; 2022 Sep; 5(9):e2233730. PubMed ID: 36169955
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
12. Risks of incident major osteoporotic fractures following SARS-CoV-2 infection among older individuals: a population-based cohort study in Hong Kong.
Lui DTW; Xiong X; Cheung CL; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Chung MSH; Au ICH; Lee CH; Ip TP; Woo YC; Tan KCB; Wong CKH; Wong ICK
J Bone Miner Res; 2024 May; 39(5):551-560. PubMed ID: 38477768
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
15. Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19-Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021.
Muhsen K; Maimon N; Mizrahi AY; Varticovschi B; Bodenheimer O; Cohen D; Dagan R
JAMA Netw Open; 2022 Jul; 5(7):e2219940. PubMed ID: 35796153
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and Risk for Mental Disorders Among Adults in Denmark.
Nersesjan V; Christensen RHB; Kondziella D; Benros ME
JAMA Psychiatry; 2023 Aug; 80(8):778-786. PubMed ID: 37223890
[TBL] [Abstract][Full Text] [Related]
17. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
[TBL] [Abstract][Full Text] [Related]
18. Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.
Butt AA; Dargham SR; Chemaitelly H; Al Khal A; Tang P; Hasan MR; Coyle PV; Thomas AG; Borham AM; Concepcion EG; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
JAMA Intern Med; 2022 Feb; 182(2):197-205. PubMed ID: 34935861
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection.
Lewis N; Chambers LC; Chu HT; Fortnam T; De Vito R; Gargano LM; Chan PA; McDonald J; Hogan JW
JAMA Netw Open; 2022 Jul; 5(7):e2223917. PubMed ID: 35895058
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
